Back to today’s briefing

Story perspectives

New Ultrasound Dose Boosts Glioblastoma Treatment Efficacy

8/26/2025

26 2

Summary

Story summary

Researchers at Mass General Brigham identified acoustic emission dose as crucial for improving focused ultrasound treatments for glioblastoma.
The study analyzed 972 ultrasound applications on 23 patients, revealing an optimal dose range of 0.5 to 1.6 for effective blood-brain barrier opening.
This advancement could enhance drug delivery to brain tumors, addressing treatment challenges for aggressive cancers.

1 of 1

Story summary

Researchers at Mass General Brigham identified acoustic emission dose as crucial for improving focused ultrasound treatments for glioblastoma.
The study analyzed 972 ultrasound applications on 23 patients, revealing an optimal dose range of 0.5 to 1.6 for effective blood-brain barrier opening.
This advancement could enhance drug delivery to brain tumors, addressing treatment challenges for aggressive cancers.